|
End-of-day quote
Shenzhen S.E.
30/09/2026
|
5-day change | 1st Jan Change | ||
| 3.650 CNY | +5.19% |
|
+0.27% | +18.89% |
| Market Cap | 8.14B 1.21B 1.08B 1.01B 918M 1.73B 117B 1.75B 12.18B 4.72B 59.45B 4.55B 4.45B 191B | P/E 2024 |
24.2x | P/E 2025 | 18.2x |
|---|---|---|---|---|---|
| Enterprise Value | 7.3B 1.09B 966M 903M 823M 1.55B 105B 1.57B 10.93B 4.23B 53.33B 4.08B 3.99B 171B | EV / Sales 2024 |
2.12x | EV / Sales 2025 | 2.82x |
| Free-Float |
90.63% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +5.19% | ||
| 1 week | +0.27% | ||
| 1 month | -16.48% | ||
| 3 months | +35.19% | ||
| 6 months | +4.89% | ||
| Current year | +18.89% |
| 1 week | 3.38 |  | 3.76 |
| 1 month | 3.3 | | 4.75 |
| Current year | 2.37 | | 5.1 |
| 1 year | 2.37 | | 5.1 |
| 3 years | 1.66 | | 5.1 |
| 5 years | 1.66 | | 5.1 |
| 10 years | 1.66 | | 9.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
Lei Feng Guo
CEO | Chief Executive Officer | 53 | 26/12/2022 |
Kang Zhou
PRN | Corporate Officer/Principal | 42 | 18/04/2018 |
Yue Yin Liu
PRN | Corporate Officer/Principal | 40 | 23/05/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Yue Yin Liu
BRD | Director/Board Member | 40 | 14/03/2025 |
Lei Feng Guo
BRD | Director/Board Member | 53 | 11/11/2022 |
Kang Zhou
BRD | Director/Board Member | 42 | 11/11/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 7/2/25 A | Sell | 587,500 | 0.0283% | |||
| 7/2/25 A | Sell | Director | 259,600 | 0.0125% | ||
| 7/2/25 A | Sell | 587,500 | 0.0283% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +5.19% | +0.27% | +18.12% | +61.50% | 1.21B | |
| -0.62% | -2.71% | +39.30% | +114.07% | 1,031B | |
| -2.30% | -4.44% | +39.03% | +66.07% | 638B | |
| -0.63% | -1.96% | +6.36% | +74.38% | 462B | |
| -1.03% | -2.82% | +59.56% | +39.69% | 359B | |
| -0.03% | -3.91% | +34.28% | +39.35% | 335B | |
| -1.58% | +0.39% | +17.92% | +25.77% | 273B | |
| -2.02% | -3.20% | +7.60% | +8.38% | 253B | |
| -3.38% | +0.30% | +36.44% | +51.54% | 228B | |
| -1.04% | -1.46% | +32.70% | +96.82% | 185B | |
| Average | -0.75% | -0.87% | +29.13% | +57.76% | 376.51B | |
| Weighted average by Cap. | -1.25% | -1.57% | +32.51% | +69.18% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.44B 364M 323M 302M 275M 518M 35.01B 525M 3.65B 1.41B 17.83B 1.37B 1.34B 57.26B | 2.14B 318M 283M 264M 241M 453M 30.63B 460M 3.2B 1.24B 15.6B 1.19B 1.17B 50.1B |
| Net income | 233M 34.67M 30.8M 28.8M 26.25M 49.41M 3.34B 50.09M 348M 135M 1.7B 130M 127M 5.46B | 377M 56.15M 49.87M 46.64M 42.5M 80.01M 5.41B 81.11M 564M 218M 2.75B 211M 206M 8.84B |
| Net Debt | -509M -75.78M -67.31M -62.94M -57.36M -108M -7.3B -109M -761M -295M -3.72B -285M -278M -11.93B | -838M -125M -111M -104M -94.5M -178M -12.02B -180M -1.25B -486M -6.12B -469M -459M -19.66B |
Employees
2,350
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/09/26 | CN¥3.650 | +5.19% | 353,814,507 |
| 29/09/26 | CN¥3.470 | +0.58% | 190,192,890 |
| 28/09/26 | CN¥3.450 | -1.43% | 155,925,393 |
| 24/09/26 | CN¥3.500 | -3.85% | 184,443,421 |
| 23/09/26 | CN¥3.640 | -3.70% | 251,293,444 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 002437 Stock
Select your edition
All financial news and data tailored to specific country editions
